Sign in
CompletedNo phase

Diagnostics of Clinical Hyperandrogenism

Key facts

Who runs it
Jagiellonian University
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,330 people enrolled
Started
29 Feb 2024
Ended
30 Oct 2025
Type of study
Observational, 2 groups
Treatments tested
  • Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale
  • Assessment of the severity of endogenetic alopecia using the visual Ludwig Scale
Record updated
2 April 2026

Who can take part

Age
18 years to 45 years
Sex
Women only

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • oligoovulation, i.e. menstrual cycles every <21 days or >35 days
  • age 18-45 years

Who cannot take part

  • virilizing tumors
  • congenital adrenal hyperplasia
  • ovarian hyperthecosis

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The optimal cut-off value for diagnosing hirsutism in the modified Ferriman-Gallwey (mFG) point scale in the Polish population is not known. The correlation of mFG with the severity of androgenetic alopecia in the Ludwig scale (LS) is not known.

Read full original descriptionShow less

The aim of the study is to determine the cut-off point for the diagnosis of hirsutism and to assess the correlation of the mFG scale score with the LS of androgenetic alopecia severity.

The 2 groups in the trial

  • Polycystic ovary syndrome (PCOS)

    Women diagnosed with polycystic ovary syndrome based on International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome (2023)

    Treatment: Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale and Assessment of the severity of endogenetic alopecia using the visual Ludwig Scale

  • Hypothalamic-pituitary-ovarian dysfunction (HPOD)

    Women diagnosed with hypothalamic-pituitary-ovarian dysfunction based on The FIGO ovulatory disorders classification system (2022)

    Treatment: Assessment of the severity of hirsutism using the visual modified Ferriman-Gallwey scale and Assessment of the severity of endogenetic alopecia using the visual Ludwig Scale

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Diagnostics of Clinical Hyperandrogenism Using the Modified Ferriman-Gallwey Scale and the Ludwig Scale in Women With Normogonadotropic Anovulation
Record updated
2 April 2026